Stemtech Corporation

STEK ·Healthcare, Medical Distribution, United States
Financial Statements › Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2017 FY2016 FY2015 FY2014 FY2013 FY2012
Operating Activities
Net Income $-46.3K $-28.4K $-19.8K $-38.5K $-31.0K $-29.0K
Depreciation & Amortization — — — — — —
Depreciation — — — — — —
Amortization — — — — — —
Stock-Based Compensation — — — — — —
Net Cash from Operating Activities $-24.8K $-37.0K $-17.2K $-31.7K $-36.8K $-19.8K
Investing Activities
Capital Expenditures — — — — — —
Business Acquisitions — — — — — —
Net Cash from Investing Activities $-10.2K $-625 — $0 $0 $0
Financing Activities
Dividends Paid — — — — — —
Stock Repurchases — — — — — —
Net Cash from Financing Activities $40.0K $40.5K — $30.0K $55.0K $20.0K
Net Change in Cash $4.9K $2.9K $-17.2K $-1.7K $18.2K $151
Free Cash Flow — — — — — —
← Newer Page 2 of 2 Older →